{
  "days": 31,
  "websites": [
    {
      "name": "Editas Medicine",
      "url": "editasmedicine.com",
      "real": "https://ir.editasmedicine.com/press-releases"
    },
    {
      "name": "Intellia Therapeutics",
      "url": "intelliatx.com",
      "real": "https://ir.intelliatx.com/news-releases"
    },
    {
      "name": "CRISPR Therapeutics",
      "url": "crisprtx.com",
      "real": "http://www.crisprtx.com/about-us/press-releases-and-presentations/all-press"
    },
    {
      "name": "Beam Therapeutics",
      "url": "beamtx.com",
      "real": "https://investors.beamtx.com/press-releases"
    },
    {
      "name": "Bluebird Bio",
      "url": "bluebirdbio.com",
      "real": "http://investor.bluebirdbio.com/news-releases"
    },
    {
      "name": "Sarepta Therapeutics",
      "url": "sarepta.com",
      "real": "https://investorrelations.sarepta.com/press-releases"
    },
    {
      "name": "RegenxBio",
      "url": "regenxbio.com",
      "real": "https://regenxbio.gcs-web.com/press-releases"
    },
    {
      "name": "MeiraGTx",
      "url": "meiragtx.com",
      "real": "https://investors.meiragtx.com/news-releases"
    },
    {
      "name": "Orchard Therapeutics",
      "url": "orchard-tx.com",
      "real": "https://ir.orchard-tx.com/news-events/press-releases"
    },
    {
      "name": "Axovant Gene Therapies",
      "url": "axovant.com",
      "real": "http://investors.axovant.com/investors/press-releases"
    },
    {
      "name": "Passage Bio",
      "url": "passagebio.com",
      "real": "https://investors.passagebio.com/news-and-events/press-releases"
    },
    {
      "name": "Rocket Pharmaceuticals",
      "url": "rocketpharma.com",
      "real": "https://rocketpharmaceuticals.gcs-web.com/news-releases"
    },
    {
      "name": "Decibel Therapeutics",
      "url": "decibeltx.com",
      "real": "https://www.decibeltx.com/news/"
    },
    {
      "name": "Sana Biotechnology",
      "url": "sana.com",
      "real": "https://sana.com/category/press-release/"
    },
    {
      "name": "Century Therapeutics",
      "url": "centurytx.com",
      "real": "https://www.centurytx.com/media-news-pr"
    },
    {
      "name": "Allogene Therapeutics",
      "url": "allogene.com",
      "real": "https://ir.allogene.com/press-releases"
    },
    {
      "name": "Unity Biotechnology",
      "url": "unitybiotechnology.com",
      "real": "http://ir.unitybiotechnology.com/press-releases"
    },
    {
      "name": "Navitor Pharmaceuticals",
      "url": "navitorpharma.com",
      "real": "http://www.navitorpharma.com/news/press-releases/"
    },
    {
      "name": "resTOR Bio",
      "url": "restorbio.com",
      "real": "https://ir.restorbio.com/news-and-events/news-releases"
    },
    {
      "name": "Arsenal Bio",
      "url": "arsenalbio.com",
      "real": "https://www.arsenalbio.com/"
    },
    {
      "name": "Sonoma Biosciences",
      "url": "sonomapharma.com",
      "real": "https://ir.sonomapharma.com/press-releases"
    },
    {
      "name": "uniQure NV",
      "url": "uniqure.com",
      "real": "http://uniqure.com/investors-newsroom/press-releases.php"
    },
    {
      "name": "Harpoon Therapeutics",
      "url": "https://ir.harpoontx.com/news-releases",
      "real": "T cell engager therapies vs. ovarian and prostate cancer"
    },
    {
      "name": "Black Diamond Therapeutics",
      "url": "https://investors.blackdiamondtherapeutics.com/news-and-events/news-releases",
      "real": "Targeted kinase inhibitors vs. HER2, EGFR cancers"
    },
    {
      "name": "Cabaletta Therapeutics",
      "url": "https://investors.cabalettabio.com/news-events/news-releases",
      "real": "Chimeric autoantigen receptor therapies vs autoimmune diseases"
    },
    {
      "name": "TCR2 Therapeutics",
      "url": "http://investors.tcr2.com/news-releases",
      "real": "Engineered TCR therapies vs. cancer"
    },
    {
      "name": "Adaptimmune",
      "url": "https://ir.adaptimmune.com/news-releases?c=253991&nyo=0&p=irol-news",
      "real": ""
    },
    {
      "name": "AgeX Therapeutics",
      "url": "https://investors.agexinc.com/news/default.aspx",
      "real": "Cell therapies for age-related disorders"
    },
    {
      "name": "Blueprint Medicines",
      "url": "http://ir.blueprintmedicines.com/news-releases",
      "real": "Targeted kinase inhibitors"
    },
    {
      "name": "Deciphera Therapeutics",
      "url": "https://investors.deciphera.com/news-events/press-releases",
      "real": "Targeted kinase inhibitors"
    },
    {
      "name": "Atara Bio",
      "url": "https://investors.atarabio.com/news-events",
      "real": "Allogeneic t cell therapies vs. cancer/autoimmune dz"
    },
    {
      "name": "Ideaya Biosciences",
      "url": "https://ir.ideayabio.com/news-events/news-releases",
      "real": "Synthetic lethality/PARP/PARG inhibitors"
    }
  ],
  "sender": "troyks00055@gmail.com",
  "receiver": "c.sato.dev@gmail.com",
  "webdriver": "D:\\driver\\chromedriver.exe",
  "sendgrid": "SG.1DAR1P4PQaa-v14bMHAPIA.0sbpjSHAi_a7Gf8_4d9IkP3IN_dWAWNybZ9KPEPA5iM"
}
